Electroconvulsive Therapy Legal Status

Electroconvulsive therapy (ECT) is one of the most controversial therapies used in medicine today. While some psychiatrists believe that ECT is an effective, life-saving psychiatric treatment, others have grave concerns about its use and the associated side effects.

Informed consent

The term “informed consent” refers to the consent given by a patient to proceed with a therapeutic approach after they have been fully informed of the benefits and risks associated with the therapy. The patient’s written consent is obtained prior to initiation of an ECT treatment plan. A 2005 publication from the World Health Organization entitled “Human Rights and Legislation WHO Resource Book on Mental Health” states that ECT can be administered only after informed consent has been obtained from the patient.

In the United States, any doctor treating a patient is under a legal obligation to ensure that the patient understands the following points before they undergo ECT:

  • The reason for the treatment
  • The risks associated with the ECT treatment plan.
  • The risks and benefits of alternative treatments at the stage of disease concerned
  • The risks and benefits of not receiving any ECT therapy versus receiving therapy

Once these facts are explained, the patient is given the opportunity to reject or accept the treatment. At any time during the course of the treatment plan, the patient retains the right to refuse the treatment and revoke his or her informed consent.

Until 2009, the use of ECT to treat detained patients was allowed in England and Wales under the 1983 Mental Health Act, regardless of whether their consent had been obtained. However, the treatment could only be administered if it was authorized by a psychiatrist from the Mental Health Act Commission’s panel.

After 2009, the law was altered and now ECT cannot be given to any patient who is able to refuse consent. Emergency administration may still be allowed regardless of capacity to consent, if a psychiatrist says the treatment is urgently needed (under Section 62 of the Act).

Further Reading

Last Updated: Jun 12, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 12). Electroconvulsive Therapy Legal Status. News-Medical. Retrieved on October 31, 2024 from https://www.news-medical.net/health/Electroconvulsive-Therapy-Legal-Status.aspx.

  • MLA

    Mandal, Ananya. "Electroconvulsive Therapy Legal Status". News-Medical. 31 October 2024. <https://www.news-medical.net/health/Electroconvulsive-Therapy-Legal-Status.aspx>.

  • Chicago

    Mandal, Ananya. "Electroconvulsive Therapy Legal Status". News-Medical. https://www.news-medical.net/health/Electroconvulsive-Therapy-Legal-Status.aspx. (accessed October 31, 2024).

  • Harvard

    Mandal, Ananya. 2023. Electroconvulsive Therapy Legal Status. News-Medical, viewed 31 October 2024, https://www.news-medical.net/health/Electroconvulsive-Therapy-Legal-Status.aspx.

Comments

  1. Rajat Deep Rajat Deep India says:

    Many patients are still treated in India with ECT. A strong law is required in India which regulates the use of this treatment here.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.